Serum total bilirubin concentration in patients with type 2 diabetes as a possible biomarker of polyvascular disease

Takeshi Nishimura, Masami Tanaka, Risa Sekioka, Hiroshi Itoh

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aims: The aim of this study was to investigate the association between serum total bilirubin concentration and complicated macrovascular diseases, such as cerebrovascular disease (CBVD), cardiovascular disease (CAD), and peripheral arterial disease (PAD), in patients with type 2 diabetes. Methods: We performed a retrospective cross-sectional study in 674 patients with type 2 diabetes. Serum total bilirubin concentration was compared between patients with and without CBVD, CAD, and PAD. Logistic regression analyses were performed to identify risk factors for CBVD, CAD, and PAD. Associations between total bilirubin concentration and the number of complicated macrovascular diseases were analyzed. Results: Patients with CBVD and PAD showed significantly lower serum total bilirubin concentrations than did those patients without those diseases. However, the bilirubin concentration did not differ between patients with and without CAD. Total bilirubin concentration was an independent predictor of CBVD, but not of CAD or PAD. There was a statistically significant trend for a decrease in bilirubin concentration in the presence of an increasing number of macrovascular diseases. Conclusion: The presence of more than one macrovascular disease, called polyvascular disease, carries a high risk for cardiovascular mortality. Serum total bilirubin concentration may be useful as a clinical biomarker of polyvascular disease.

Original languageEnglish
Pages (from-to)129-135
Number of pages7
JournalDiabetology International
Volume9
Issue number2
DOIs
Publication statusPublished - 2018 May 1

Fingerprint

Bilirubin
Type 2 Diabetes Mellitus
Cerebrovascular Disorders
Biomarkers
Peripheral Arterial Disease
Serum
Cardiovascular Diseases
Cross-Sectional Studies
Logistic Models
Regression Analysis
Mortality

Keywords

  • Atherosclerosis
  • Cerebrovascular disease
  • Coronary artery disease
  • Peripheral arterial disease
  • Polyvascular disease
  • Total bilirubin

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Serum total bilirubin concentration in patients with type 2 diabetes as a possible biomarker of polyvascular disease. / Nishimura, Takeshi; Tanaka, Masami; Sekioka, Risa; Itoh, Hiroshi.

In: Diabetology International, Vol. 9, No. 2, 01.05.2018, p. 129-135.

Research output: Contribution to journalArticle

@article{1ce0301be43d48dca7133573c6953bf7,
title = "Serum total bilirubin concentration in patients with type 2 diabetes as a possible biomarker of polyvascular disease",
abstract = "Aims: The aim of this study was to investigate the association between serum total bilirubin concentration and complicated macrovascular diseases, such as cerebrovascular disease (CBVD), cardiovascular disease (CAD), and peripheral arterial disease (PAD), in patients with type 2 diabetes. Methods: We performed a retrospective cross-sectional study in 674 patients with type 2 diabetes. Serum total bilirubin concentration was compared between patients with and without CBVD, CAD, and PAD. Logistic regression analyses were performed to identify risk factors for CBVD, CAD, and PAD. Associations between total bilirubin concentration and the number of complicated macrovascular diseases were analyzed. Results: Patients with CBVD and PAD showed significantly lower serum total bilirubin concentrations than did those patients without those diseases. However, the bilirubin concentration did not differ between patients with and without CAD. Total bilirubin concentration was an independent predictor of CBVD, but not of CAD or PAD. There was a statistically significant trend for a decrease in bilirubin concentration in the presence of an increasing number of macrovascular diseases. Conclusion: The presence of more than one macrovascular disease, called polyvascular disease, carries a high risk for cardiovascular mortality. Serum total bilirubin concentration may be useful as a clinical biomarker of polyvascular disease.",
keywords = "Atherosclerosis, Cerebrovascular disease, Coronary artery disease, Peripheral arterial disease, Polyvascular disease, Total bilirubin",
author = "Takeshi Nishimura and Masami Tanaka and Risa Sekioka and Hiroshi Itoh",
year = "2018",
month = "5",
day = "1",
doi = "10.1007/s13340-017-0337-8",
language = "English",
volume = "9",
pages = "129--135",
journal = "Diabetology International",
issn = "2190-1678",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Serum total bilirubin concentration in patients with type 2 diabetes as a possible biomarker of polyvascular disease

AU - Nishimura, Takeshi

AU - Tanaka, Masami

AU - Sekioka, Risa

AU - Itoh, Hiroshi

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Aims: The aim of this study was to investigate the association between serum total bilirubin concentration and complicated macrovascular diseases, such as cerebrovascular disease (CBVD), cardiovascular disease (CAD), and peripheral arterial disease (PAD), in patients with type 2 diabetes. Methods: We performed a retrospective cross-sectional study in 674 patients with type 2 diabetes. Serum total bilirubin concentration was compared between patients with and without CBVD, CAD, and PAD. Logistic regression analyses were performed to identify risk factors for CBVD, CAD, and PAD. Associations between total bilirubin concentration and the number of complicated macrovascular diseases were analyzed. Results: Patients with CBVD and PAD showed significantly lower serum total bilirubin concentrations than did those patients without those diseases. However, the bilirubin concentration did not differ between patients with and without CAD. Total bilirubin concentration was an independent predictor of CBVD, but not of CAD or PAD. There was a statistically significant trend for a decrease in bilirubin concentration in the presence of an increasing number of macrovascular diseases. Conclusion: The presence of more than one macrovascular disease, called polyvascular disease, carries a high risk for cardiovascular mortality. Serum total bilirubin concentration may be useful as a clinical biomarker of polyvascular disease.

AB - Aims: The aim of this study was to investigate the association between serum total bilirubin concentration and complicated macrovascular diseases, such as cerebrovascular disease (CBVD), cardiovascular disease (CAD), and peripheral arterial disease (PAD), in patients with type 2 diabetes. Methods: We performed a retrospective cross-sectional study in 674 patients with type 2 diabetes. Serum total bilirubin concentration was compared between patients with and without CBVD, CAD, and PAD. Logistic regression analyses were performed to identify risk factors for CBVD, CAD, and PAD. Associations between total bilirubin concentration and the number of complicated macrovascular diseases were analyzed. Results: Patients with CBVD and PAD showed significantly lower serum total bilirubin concentrations than did those patients without those diseases. However, the bilirubin concentration did not differ between patients with and without CAD. Total bilirubin concentration was an independent predictor of CBVD, but not of CAD or PAD. There was a statistically significant trend for a decrease in bilirubin concentration in the presence of an increasing number of macrovascular diseases. Conclusion: The presence of more than one macrovascular disease, called polyvascular disease, carries a high risk for cardiovascular mortality. Serum total bilirubin concentration may be useful as a clinical biomarker of polyvascular disease.

KW - Atherosclerosis

KW - Cerebrovascular disease

KW - Coronary artery disease

KW - Peripheral arterial disease

KW - Polyvascular disease

KW - Total bilirubin

UR - http://www.scopus.com/inward/record.url?scp=85046642410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046642410&partnerID=8YFLogxK

U2 - 10.1007/s13340-017-0337-8

DO - 10.1007/s13340-017-0337-8

M3 - Article

AN - SCOPUS:85046642410

VL - 9

SP - 129

EP - 135

JO - Diabetology International

JF - Diabetology International

SN - 2190-1678

IS - 2

ER -